Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Gajewski

Showing results (81-90 of 236) with videos related to

Pageof 24
Sort By:
Molecular and Cellular Biology|January 30, 2004
Actin cytoskeleton regulates calcium dynamics and NFAT nuclear durationFabiola V Rivas, James P O'Keefe, Maria-Luisa Alegre, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2012
Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferationJustin Kline, Long Zhang, Lauren Battaglia, et al.
Journal for Immunotherapy of Cancer|July 18, 2018
Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumabAndrew Hantel, Brooke Gabster, Jason X Cheng, et al.
Advances in Experimental Medicine and Biology|December 25, 2017
Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor MicroenvironmentThomas F Gajewski, Leticia Corrales, Jason Williams, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2006
Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascitesHelena Harlin, Todd V Kuna, Amy C Peterson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cellsChristian Blank, Ian Brown, Reinhard Marks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2019
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human CancersJason J Luke, Riyue Bao, Randy F Sweis, et al.
European Journal of Immunology|August 7, 2009
Homeostatic proliferation of naïve CD8+ T cells depends on CD62L/L-selectin-mediated homing to peripheral LNKerstin Schuster, Jules Gadiot, Reinhard Andreesen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2013
Conditional deletion of PTEN in peripheral T cells augments TCR-mediated activation but does not abrogate CD28 dependency or prevent anergy inductionFrederick L Locke, Yuan-yuan Zha, Yan Zheng, et al.
Cancer Immunology Research|November 4, 2017
Intratumoral CD8<sup>+</sup> T-cell Apoptosis Is a Major Component of T-cell Dysfunction and Impedes Antitumor ImmunityBrendan L Horton, Jason B Williams, Alexandra Cabanov, et al.
Pageof 24

Showing results (81-90 of 236) with videos related to

Sort By:
Pageof 24
Molecular and Cellular Biology|January 30, 2004
Actin cytoskeleton regulates calcium dynamics and NFAT nuclear durationFabiola V Rivas, James P O'Keefe, Maria-Luisa Alegre, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2012
Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferationJustin Kline, Long Zhang, Lauren Battaglia, et al.
Journal for Immunotherapy of Cancer|July 18, 2018
Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumabAndrew Hantel, Brooke Gabster, Jason X Cheng, et al.
Advances in Experimental Medicine and Biology|December 25, 2017
Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor MicroenvironmentThomas F Gajewski, Leticia Corrales, Jason Williams, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2006
Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascitesHelena Harlin, Todd V Kuna, Amy C Peterson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cellsChristian Blank, Ian Brown, Reinhard Marks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2019
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human CancersJason J Luke, Riyue Bao, Randy F Sweis, et al.
European Journal of Immunology|August 7, 2009
Homeostatic proliferation of naïve CD8+ T cells depends on CD62L/L-selectin-mediated homing to peripheral LNKerstin Schuster, Jules Gadiot, Reinhard Andreesen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2013
Conditional deletion of PTEN in peripheral T cells augments TCR-mediated activation but does not abrogate CD28 dependency or prevent anergy inductionFrederick L Locke, Yuan-yuan Zha, Yan Zheng, et al.
Cancer Immunology Research|November 4, 2017
Intratumoral CD8<sup>+</sup> T-cell Apoptosis Is a Major Component of T-cell Dysfunction and Impedes Antitumor ImmunityBrendan L Horton, Jason B Williams, Alexandra Cabanov, et al.
Pageof 24